Servetto, A.; Santaniello, A.; Napolitano, F.; Foschini, F.; Marciano, R.; Mozzillo, E.; Cascetta, P.; Amato, A.R.; Augurio, M.R.; Maresca, L.;
et al. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers 2021, 13, 4939.
https://doi.org/10.3390/cancers13194939
AMA Style
Servetto A, Santaniello A, Napolitano F, Foschini F, Marciano R, Mozzillo E, Cascetta P, Amato AR, Augurio MR, Maresca L,
et al. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers. 2021; 13(19):4939.
https://doi.org/10.3390/cancers13194939
Chicago/Turabian Style
Servetto, Alberto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca,
and et al. 2021. "Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study" Cancers 13, no. 19: 4939.
https://doi.org/10.3390/cancers13194939
APA Style
Servetto, A., Santaniello, A., Napolitano, F., Foschini, F., Marciano, R., Mozzillo, E., Cascetta, P., Amato, A. R., Augurio, M. R., Maresca, L., De Placido, P., De Placido, S., Formisano, L., & Bianco, R.
(2021). Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers, 13(19), 4939.
https://doi.org/10.3390/cancers13194939